止痛药市场：化挑战为机会－掌握自我照护止痛市场的机会

过去几年，全球止痛药市场保持稳定成长，但随着后疫情时代消费模式的恢復，成长速度有所放缓。全身用药正朝着起效更快、更方便的方向发展，复方製剂和新兴趋势正在某些市场扩大该品类。感冒和流感的盛行率在不同市场差异显着，儿童止痛药在低流行地区受到的衝击尤为严重。外用止痛药则受益于人们积极参与运动的增加、老年人口的增长以及缓解经期不适的新产品。

网路和邮购销售的成长速度持续超过实体店销售，线上通路的占有率不断扩大，一些热门止痛药产品也呈现显着成长。为了打造差异化品牌，A+P 正着眼于各年龄层的消费者，结合多种促销策略和媒体管道，并日益强调包容性和社会责任。

不同市场的新产品开发重点各不相同。近期推出的产品包括：澳洲全球首款塞来昔布转换剂型、德国首款右旋布洛芬，以及一家大型感冒咳嗽药品牌进军美国全身及局部止痛药市场。创新剂型层出不穷，例如容易吞嚥的迷你胶囊、鼻喷剂、依摩球和笔状涂抹器。针对不同人群（包括青少年、上班族、运动爱好者和匹克球运动员）的区隔产品正在拓展该品类。同时，成熟的止痛药品牌也越来越多地进军关节保健品领域。

市场动态的销售预测与历史成长基本上一致，但在这个成熟的市场中，行销人员如何找到新的活力？他们如何利用近期趋势和发展，或拓展产品线以开闢新的区隔市场？

本报告探讨了影响全球止痛药物市场的紧迫问题，深入分析了多个相关领域，并重点介绍了独特的机会。透过详细检视12个主要市场（并简要介绍其他主要市场），分析品牌表现和上市活动，我们的 "止痛" 报告挖掘了这个保健保健品类别的巨大潜力。

报告主要特点

• 对止痛市场进行详区隔析，包括全身用药、外用药和口腔/牙科止痛药。
• 检视全球16个主要市场，涵盖销售、品牌表现、最新进展、产品上市及促销活动。
• 同时检视关节保健品，这是一个重要的维生素、矿物质和膳食补充剂（VMS）相关类别。
• 我们专门的CHC销售资料库，包含6个独立的资料库。除了截至2024年底的最新销售数据外，本报告还提供截至2020年的历史成长率以及截至2025年中期的各类别销售额成长率。 每个国家的品类销售额均依组成部分区隔。 报告中还包含各市场的互联网和邮购销售额。 全面涵盖行销活动，包括策略、成功因素、销售、新产品开发活动以及面向消费者和医疗保健专业人员的促销活动。
• 所有类别和国家的长期预测（至 2029 年和 2034 年），以及更新的短期预测（至 2025 年和 2026 年）

本报告涵盖的类别

*VMSinDB6 中追踪的销售量。

12个独立市场的详区隔析

其他市场

本报告包​​含截至2024年底的DB6资料库最新销售数据。报告提供依国家和类别划分的全球销售额、各品牌表现以及至2029年和2034年的长期预测。报告也涵盖线上管道，并设有专门章节介绍止痛药线上销售及各国概况。

本报告深入分析影响各个镇痛药市场的因素，涵盖消费者趋势、监管变化、广告宣传活动和新产品上市等，并详细阐述了12个国家的市场趋势和发展动态，以及其他主要市场的更详细概况，包括洞察分析和预测。

本报告探讨的关键问题

• 可以从最成功的止痛药行销商和品牌中学到什么？
• 新产品开发是否有利于市场并为其成长指明方向？
• 考虑竞争格局、消费者偏好、电子商务环境和未来推动因素，哪些市场最具发展潜力？
• 能否发现新的利基市场或服务不足的市场区隔？
• 关节保健品这一相邻品类是否值得探索？
• 止痛药的前景和商机是什么？

在国别数据分析中，依主要成分分析了2024年全身和外用止痛药的销售数据。

我们也探讨了一个重要的邻近类别－关节保健品，NPD认为该类别正在推动整个品类的扩张。

对于短期展望，我们提供了各市场所有品类2025年和2026年的预测。

随着止痛药上市速度逐年放缓，市场需要从追求数量转向追求品质。

目录

摘要整理

• 全球疼痛缓解市场概览
• 新产品开发与创新概览
• 全身性疼痛缓解
• 局部性疼痛缓解
• 口腔及牙齿疼痛缓解
• 线上及邮购疼痛缓解
• 关节保健补充剂
• CBD/医用大麻用于疼痛缓解
• 展望、预测及机遇

美国

• 概述
• 全身性疼痛缓解
• 局部性疼痛缓解
• 口腔及牙齿疼痛缓解
• 线上及邮购疼痛缓解
• 关节保健补充剂
• 展望、预测及机遇机遇

中国

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 网路和邮购
• 关节保健品
• 展望、预测与机遇

法国

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 网路和邮购
• 关节保健品
• 展望、预测与机遇

巴西

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 网路和邮购
• 关节保健品保健品
• 展望、预测与机遇

德国

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 网路和邮购
• 关节保健品
• 展望、预测与机遇

印度

• 概述
• 全身性止痛药
• 外用止痛药
• 网路和邮购
• 关节保健品
• 展望、预测与机遇

日本

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 网路和邮购
• 关节保健品保健品
• 展望、预测与机遇

英国

• 概述摘要
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 线上和邮购
• 关节保健品
• 展望、预测与机遇

义大利

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药
• 线上和邮购
• 关节保健品
• 展望、预测与机遇

波兰

• 概述
• 全身性止痛药
• 外用止痛药
• 口腔和牙科止痛药止痛药
• 线上及邮购
• 关节保健品
• 展望、预测及机遇

墨西哥

• 概述
• 全身性止痛药
• 局部止痛药
• 口腔和牙齿止痛药
• 网路和邮购
• 关节保健品
• 前景、预测与机遇

澳洲

• 概述
• 全身性止痛药
• 局部止痛药
• 关节保健品
• 前景、预测与机遇

其他市场

• 加拿大
• 俄罗斯
• 韩国
• 西班牙

前景

• 短期预测和机遇
• 长期预测与机遇

Analgesics globally have sustained steady growth in recent years, albeit slowing as purchasing patterns returned to normal post-Covid. Systemics show a trend towards faster-acting, more convenient options, while combinations and new switches expand the category in selected markets. Incidence of cold & flu, which varies considerably between markets, has been a strong influence, with paediatric fever relievers particularly hard hit in areas of low incidence. Topicals benefit from rising participation in active pursuits, a growing elderly population and new products to relieve menstrual discomfort.

Internet & mail order sales continue to grow more dynamically than store retail, seeing the channel account for a growing share, as several top-tier analgesics enjoy standout online channel growth. In an effort to differentiate brands, A+P has targeted both ends of the age spectrum, with a mix of promotional strategies and media employed, with inclusivity and social responsibility increasingly to the fore.

NPD focus varies across markets. Recent launch activity has seen the world-first switch of celecoxib in Australia, Germany's first dexibuprofen launch and the main cough & cold franchise enter both systemic and topical analgesics in USA. Format innovation includes easy-to-swallow and mini-capsule options, plus nasal sprays, massage balls and pen applicators, while niche products for demographics as diverse as teenagers, office workers, sports enthusiasts and even pickleball players are expanding the category. Meanwhile, established analgesics brands are increasingly crossing into joint health supplements.

Forecast sales for Analgesics are largely consistent with previous growth, so where can marketers look to find dynamism in this mature market? How will they take advantage of the latest trends & developments or expand their offerings to exploit new niches?

This report will investigate pressing issues affecting Analgesics globally, digging into multiple areas of interest and highlighting inherent opportunities. Examining 12 core markets in detail (and additional key markets in brief), analysing brand performances and launch activity, our Analgesics report will investigate the untapped potential in this CHC category.

Key features of the report:

• An in-depth exploration of the pain relief market, including Systemic analgesics, Topical analgesics and Mouth & dental analgesics
• Coverage of 16 major markets from across the globe, with topline sales,brand performances, latest developments, launches and promotional campaigns
• Key VMS adjacency joint health supplements also investigated
• Very latest year-end 2024 sales from DB6, our dedicated CHC sales database, plus historical growth rates back to 2020 and mid-2025 topline growth across categories
• Category sales segmented by ingredient in each country
• Internet & mail order channel sales for every market profiled
• Coverage of marketer activity, highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
• A look to the future includes long-term forecast sales for all categories and countries to 2029 & 2034, plus the most up-to-date short-term forecasts (to 2025 & 2026)

Categories covered in this report include:

* sales tracked under VMS in DB6.

12 individual markets profiled in depth:

Plus additional markets in brief:

The report features the latest end-2024 sales data from our dedicated DB6 database, including topline historical sales globally , by country and category, as well as individual brand performances, and long-term forecasts to 2029 and 2034 . Coverage extends to the online channel, with internet & mail order sales of Analgesics included in the topline and a dedicated section in each country profile.

Diving into the factors affecting individual Analgesics markets, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 12 in-depth country profiles with insights and predictions, as well as shorter profiles of other key markets .

Key questions investigated in this report:

• What can be learned from the most successful analgesics marketers & brands?
• Has NPD benefited the market and does it offer a route to growth?
• Which markets show the most promise based on competitive landscape, consumer preferences, e-commerce environment and future drivers?
• Can new niches and underserved demographics be identified?
• Does the adjacent category of joint health supplements merit exploring?
• What is the outlook for Analgesics and where can opportunities be found?

Data analysis within each country profile includes a breakdown of 2024 sales by key ingredient in Systemic analgesics and Topical analgesics.

The important adjacent category of joint health supplements, where NPD has helped drive category expansion, is also investigated.

Assessing the short-term outlook, the report includes full-year 2025 & 2026 forecasts for all categories in each market profiled.

With launch activity in Analgesics slowing year on year, has the impetus shifted from quantity to quality? New product development is explored across markets, including Rx-to-OTC switches, delivery format innovations, new benefits and more.

Table of Contents

Executive Summary

• Global analgesics snapshot
• NPD & innovation snapshot
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel for analgesics
• Joint health supplements
• CBD / medical cannabis for pain relief
• Outlook, forecasts & opportunities

USA

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

China

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

France

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Brazil

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Germany

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

India

• Overview
• Systemic analgesics
• Topical analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Japan

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

UK

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Italy

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Poland

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Mexico

• Overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Internet & mail order channel
• Joint health supplements
• Outlook, forecasts & opportunities

Australia

• Overview
• Systemic analgesics
• Topical analgesics
• Joint health supplements
• Outlook, forecasts & opportunities

Additional Markets

• Canada
• Russia
• South Korea
• Spain

Outlook

• Short-term forecast & opportunities
• Long-term forecast & opportunities